A Pilot Study to Compare Tobramycin 80 mg Injectable Preparation wth 300 mg Solution for Inhalation in Cystic Fibrosis Patients
BACKGROUND: Inhaled tobramycin has been shown to improve lung function in cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa. However, to date no comparative data are available for different dose regimens used in clinical practice.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2008-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2008/202464 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832568442575650816 |
|---|---|
| author | Wilfried H Nikolaizik Delia Vietzke Felix Ratjen |
| author_facet | Wilfried H Nikolaizik Delia Vietzke Felix Ratjen |
| author_sort | Wilfried H Nikolaizik |
| collection | DOAJ |
| description | BACKGROUND: Inhaled tobramycin has been shown to improve lung function in cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa. However, to date no comparative data are available for different dose regimens used in clinical practice. |
| format | Article |
| id | doaj-art-84fda2534b94436e94de20d501317ff6 |
| institution | Kabale University |
| issn | 1198-2241 |
| language | English |
| publishDate | 2008-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Respiratory Journal |
| spelling | doaj-art-84fda2534b94436e94de20d501317ff62025-02-03T00:58:59ZengWileyCanadian Respiratory Journal1198-22412008-01-0115525926210.1155/2008/202464A Pilot Study to Compare Tobramycin 80 mg Injectable Preparation wth 300 mg Solution for Inhalation in Cystic Fibrosis PatientsWilfried H Nikolaizik0Delia Vietzke1Felix Ratjen2Department of Pediatrics, University Hospital Essen, Essen, GermanyDepartment of Pediatrics, University Hospital Essen, Essen, GermanyDepartment of Pediatrics, University Hospital Essen, Essen, GermanyBACKGROUND: Inhaled tobramycin has been shown to improve lung function in cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa. However, to date no comparative data are available for different dose regimens used in clinical practice.http://dx.doi.org/10.1155/2008/202464 |
| spellingShingle | Wilfried H Nikolaizik Delia Vietzke Felix Ratjen A Pilot Study to Compare Tobramycin 80 mg Injectable Preparation wth 300 mg Solution for Inhalation in Cystic Fibrosis Patients Canadian Respiratory Journal |
| title | A Pilot Study to Compare Tobramycin 80 mg Injectable Preparation wth 300 mg Solution for Inhalation in Cystic Fibrosis Patients |
| title_full | A Pilot Study to Compare Tobramycin 80 mg Injectable Preparation wth 300 mg Solution for Inhalation in Cystic Fibrosis Patients |
| title_fullStr | A Pilot Study to Compare Tobramycin 80 mg Injectable Preparation wth 300 mg Solution for Inhalation in Cystic Fibrosis Patients |
| title_full_unstemmed | A Pilot Study to Compare Tobramycin 80 mg Injectable Preparation wth 300 mg Solution for Inhalation in Cystic Fibrosis Patients |
| title_short | A Pilot Study to Compare Tobramycin 80 mg Injectable Preparation wth 300 mg Solution for Inhalation in Cystic Fibrosis Patients |
| title_sort | pilot study to compare tobramycin 80 mg injectable preparation wth 300 mg solution for inhalation in cystic fibrosis patients |
| url | http://dx.doi.org/10.1155/2008/202464 |
| work_keys_str_mv | AT wilfriedhnikolaizik apilotstudytocomparetobramycin80mginjectablepreparationwth300mgsolutionforinhalationincysticfibrosispatients AT deliavietzke apilotstudytocomparetobramycin80mginjectablepreparationwth300mgsolutionforinhalationincysticfibrosispatients AT felixratjen apilotstudytocomparetobramycin80mginjectablepreparationwth300mgsolutionforinhalationincysticfibrosispatients AT wilfriedhnikolaizik pilotstudytocomparetobramycin80mginjectablepreparationwth300mgsolutionforinhalationincysticfibrosispatients AT deliavietzke pilotstudytocomparetobramycin80mginjectablepreparationwth300mgsolutionforinhalationincysticfibrosispatients AT felixratjen pilotstudytocomparetobramycin80mginjectablepreparationwth300mgsolutionforinhalationincysticfibrosispatients |